Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Victorian Clinical Genetics Services, |
RCV004595022 | SCV005087044 | pathogenic | Central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease | 2023-07-17 | criteria provided, single submitter | clinical testing | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0103 - Loss of function and gain of function are known mechanisms of disease in this gene and are associated with congenital central hypoventilation syndrome 1 with or without Hirschsprung disease (CCHS; MIM#209880) (PMIDs: 20301600, 31444792). Dominant-negative has also been suggested as a mechanism of disease (PMIDs: 20301600). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0112 - The condition associated with this gene has incomplete penetrance and associated the shortest five polyAla expansions (PMID: 31444792). (I) 0115 - Variants in this gene are known to have variable expressivity. Age of onset of CCHS can range from newborn to adulthood with a broad spectrum of disease severity (PMIDs: 20301600, 31444792). (I) 0208 - Variant is predicted to result in an elongated protein. (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0602 - Variant is located in a hotspot region or cluster of pathogenic variants. The majority of disease-causing variants are located in exon 3 (PMID: 31444792). (SP) 0701 - Other protein elongation variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. At least five protein elongation variants have been classified as pathogenic or likely pathogenic by clinical diagnostic laboratories and have been identified in individuals with congenital central hypoventilation syndrome, Hirschsprung disease and/or neuroblastoma (ClinVar, DECIPHER). (SP) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1204 - This variant has been shown to be de novo in the proband (parental status not tested but assumed) (by segregation analysis). (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign |